tiprankstipranks
Trending News
More News >
SciDev Ltd (AU:SDV)
ASX:SDV

SciDev Ltd (SDV) AI Stock Analysis

Compare
8 Followers

Top Page

AU:SDV

SciDev Ltd

(Sydney:SDV)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 5.2)
Rating:45Neutral
Price Target:
AU$0.24
▼(-48.04% Downside)
Action:ReiteratedDate:02/28/26
Overall score reflects pressured fundamentals and technical weakness: profitability is negative with sharply declining free cash flow, and the stock is trading below all major moving averages with bearish MACD and very low RSI/Stoch. Low leverage provides some balance, but valuation signals are limited due to negative earnings and no dividend data.
Positive Factors
Conservative leverage
A very low debt-to-equity ratio (0.13) provides durable financial flexibility and lower solvency risk. This conservatism supports the company’s ability to fund operations or strategic investments during downturns without heavy interest burdens, preserving optionality.
Stable gross margin
A sustained gross margin near 32% indicates consistent product-level pricing power or cost control in specialty chemicals. Stable gross margins create a structural buffer for profitability recovery if volumes improve and support long-term margin sustainability versus peers.
Lean operating footprint
A small headcount implies low fixed overhead and operational agility, enabling quicker cost adjustments and scalable deployment of resources. This lean structure reduces cash burn risk and supports endurance during multi-quarter demand softness.
Negative Factors
Severe FCF decline
An 88.6% drop in free cash flow growth signals a structural deterioration in cash generation. Weak FCF limits the company’s ability to invest, service obligations, or absorb shocks without tapping external capital, constraining strategic initiatives over months.
Negative profitability metrics
Negative net margin and ROE reflect persistent difficulty converting sales into shareholder returns. This undermines reinvestment capacity and indicates structural issues in either pricing, cost base, or product mix that must be remedied to restore sustainable profitability.
Declining revenue trend
Consecutive revenue declines point to weakening demand or market share loss in the specialty chemicals niche. A shrinking top line reduces operating leverage, pressures margins and makes it harder to cover fixed costs, limiting medium-term growth prospects.

SciDev Ltd (SDV) vs. iShares MSCI Australia ETF (EWA)

SciDev Ltd Business Overview & Revenue Model

Company DescriptionSciDev Limited engages in supply of process control, professional services, equipment design and construction, and chemistry in Australia and the United States. The company offers coagulants and flocculants in powder and liquid form under the MaxiFlox and MaxiDry name; engineering and process control; chemistry products for applications, including thickening, filtration, centrifuging, friction reduction, shale inhibition, rheology control, and carrier fluids; chemical batching, storage, and dosage systems; engineering solutions and technologies under the TrueMud and OptiFlox name; friction reducers under the DrySlik, WetSlik, and CarrySlik names; and dynamic shears. It serves water and wastewater treatment, mining and minerals processing, oil and gas, construction, food processing, dairy, power generation, personal products and cosmetics manufacturing, paper and cardboard manufacturing, and paint manufacturing industries. The company was formerly known as Intec Limited and changed its name to SciDev Limited in March 2017. SciDev Limited was incorporated in 1973 and is headquartered in Kings Park, Australia.
How the Company Makes MoneySciDev Ltd generates revenue primarily through the sale of its proprietary scientific instruments and software solutions, which are utilized by research institutions and commercial laboratories. Additionally, the company earns income from providing consultancy services, training programs, and technical support related to its products. Key revenue streams include direct product sales, subscription fees for software services, and project-based contracts with academic and industry partners. Strategic partnerships with leading research organizations and collaborations with other technology firms further bolster its earnings by expanding its market reach and enhancing product offerings.

SciDev Ltd Financial Statement Overview

Summary
Mixed fundamentals: revenue recently declined (-4.96%) and net margin is negative (-0.85%) with sharply weaker free cash flow growth (-88.63%). Offsetting this, gross margin is relatively stable (32.26%) and leverage is conservative (debt-to-equity 0.13), though ROE is negative (-1.75%).
Income Statement
45
Neutral
SciDev Ltd has shown fluctuating revenue growth with a recent decline of 4.96%. The gross profit margin is relatively stable at 32.26%, indicating efficient cost management. However, the net profit margin is negative at -0.85%, reflecting challenges in achieving profitability. EBIT and EBITDA margins are modest, suggesting limited operational efficiency improvements.
Balance Sheet
60
Neutral
The company maintains a low debt-to-equity ratio of 0.13, indicating conservative leverage. However, the return on equity is negative at -1.75%, highlighting challenges in generating returns for shareholders. The equity ratio is not explicitly provided, but the low debt levels suggest a stable financial structure.
Cash Flow
40
Negative
Free cash flow growth has significantly declined by 88.63%, indicating potential liquidity issues. The operating cash flow to net income ratio is low at 0.13, suggesting limited cash generation relative to earnings. The free cash flow to net income ratio is 0.27, reflecting challenges in converting earnings into cash flow.
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue101.34M103.50M109.09M89.72M55.60M42.52M
Gross Profit18.57M33.39M33.97M6.83M3.69M1.37M
EBITDA3.28M5.91M7.65M4.11M1.13M1.88M
Net Income-2.95M-878.00K2.17M-339.00K-616.00K3.45M
Balance Sheet
Total Assets71.24M75.23M72.01M67.37M71.16M56.15M
Cash, Cash Equivalents and Short-Term Investments7.52M9.68M9.43M7.73M14.06M7.01M
Total Debt6.61M6.26M5.13M3.48M2.90M5.13M
Total Liabilities23.81M25.18M21.78M19.35M22.32M24.54M
Stockholders Equity47.43M50.05M50.24M48.02M48.84M31.61M
Cash Flow
Free Cash Flow-2.13M785.00K4.48M522.00K-3.83M-1.92M
Operating Cash Flow-1.00K2.87M6.48M4.81M-1.31M-1.32M
Investing Cash Flow366.00K-2.35M-3.71M-8.39M-6.65M-2.49M
Financing Cash Flow-3.31M-390.00K-1.06M-2.83M14.99M6.34M

SciDev Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.46
Price Trends
50DMA
0.40
Negative
100DMA
0.39
Negative
200DMA
0.36
Negative
Market Momentum
MACD
-0.04
Positive
RSI
23.63
Positive
STOCH
4.68
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:SDV, the sentiment is Negative. The current price of 0.46 is above the 20-day moving average (MA) of 0.35, above the 50-day MA of 0.40, and above the 200-day MA of 0.36, indicating a bearish trend. The MACD of -0.04 indicates Positive momentum. The RSI at 23.63 is Positive, neither overbought nor oversold. The STOCH value of 4.68 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:SDV.

SciDev Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
55
Neutral
AU$37.70M-5.61-67.76%7.08%33.70%
52
Neutral
AU$24.82M-6.91-63.81%52.66%
46
Neutral
AU$240.37M-4.85-22.28%16.47%29.53%
45
Neutral
AU$46.57M-15.81-1.75%-5.37%-140.00%
41
Neutral
AU$25.64M-1.58-869.14%340.27%19.44%
37
Underperform
AU$25.02M-2.44-263.52%-32.85%28.00%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:SDV
SciDev Ltd
0.25
-0.18
-41.67%
AU:AJX
Alexium International Group
0.01
0.00
0.00%
AU:DTZ
Dotz Nano Limited
0.04
-0.04
-53.75%
AU:SPN
Sparc Technologies Ltd
0.21
0.03
16.67%
AU:CXL
Calix Ltd.
1.12
0.68
153.41%
AU:CG1
Carbonxt Group Ltd.
0.09
0.03
45.00%

SciDev Ltd Corporate Events

SciDev director Dan O’Toole lifts indirect shareholding with on-market purchase
Feb 27, 2026

SciDev Ltd has disclosed a change in director Dan O’Toole’s relevant interest in the company’s securities, reflecting an increase in his indirect shareholding through Huon Road Pty Ltd . The disclosure, lodged with the ASX, details that O’Toole acquired 106,000 fully paid ordinary shares on-market at $0.2293 per share, lifting his indirect holding to 372,000 shares while his direct holding remains 62,111 shares.

The on-market purchase signals a higher personal financial exposure by the director to SciDev’s equity, which may be interpreted by investors as a sign of confidence in the company’s prospects. The transaction occurred outside a closed period and required no special trading clearance, indicating that it was conducted under normal trading conditions within the company’s governance framework.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.23 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev Hit by Energy Disruptions and Cost Pressures in First Half FY26
Feb 25, 2026

SciDev Ltd reported a challenging first half of FY26, with revenue slipping to $47.9 million from $49.9 million a year earlier and gross margins contracting to 28%. Management attributed the weaker performance primarily to disruption in fracturing schedules within its Energy Services division and higher costs in its Overseas Water Technologies operations, which reduced reported EBITDA to $0.4 million and underlying EBITDA to $1.1 million, despite maintaining a net cash position of $4.4 million and 54% of revenue from recurring sources.

The results underscore operational headwinds in key business lines but also highlight the resilience provided by the company’s recurring revenue base and net cash position. Investors will focus on how effectively SciDev can stabilise costs in its overseas operations and restore growth in Energy Services activity to support a recovery in margins and earnings over the remainder of the financial year.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.35 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev outlines turnaround plan after challenging first half
Feb 25, 2026

SciDev reported a weaker first half of FY26, with revenue slipping to A$47.9 million and underlying EBITDA falling to A$1.1 million, as a frac schedule change at a key U.S. energy customer hit xSlik® sales and international Water Technologies investments outpaced revenues. In response, the company is shifting its international water business to a lower-cost channel partner model, diversifying its Energy Services customer base, and capitalising on record Process Chemistry results and a profitable APAC Water Technologies arm to drive second-half revenue and earnings growth.

Management has highlighted improving quarterly momentum, cost reductions at corporate level, and a strategy to expand higher-margin and recurring revenue streams, which now account for more than half of group sales. These moves, alongside R&D for next-generation specialty chemicals and cross-selling water technologies across its global customer base, aim to strengthen SciDev’s competitive position as it pursues its ambition to be a leading water technology provider to the energy and mining sectors.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.35 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev Swings to Deeper Half-Year Loss on Modest Revenue Decline
Feb 25, 2026

SciDev Limited reported half-year revenues of $47.9 million for the period ended 31 December 2025, down 4% from a year earlier, while its net loss after tax widened sharply to $2.14 million from $68,000. The result pushed basic and diluted earnings per share to a loss of 1.13 cents, compared with a 0.04 cent loss previously, and the company again did not declare a dividend.

The deterioration in earnings, despite only a modest decline in revenue, points to rising costs, margin pressure or one-off impacts weighing on profitability during the half. Net tangible assets per share also eased to 12.16 cents from 13.32 cents at 30 June 2025, suggesting a slight weakening in balance sheet backing for shareholders and underscoring a more challenging operating environment.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.35 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev sets date for 1H FY26 results and investor webcast
Feb 23, 2026

SciDev Ltd will release its first-half FY26 financial results before the market opens on 26 February 2026 and will host an investor webcast the same morning. The online briefing, led by Managing Director and CEO Seán Halpin and CFO Todd Scott, will outline the company’s 1H FY26 operational highlights and business activities and include a Q&A session for investors and shareholders.

The event underscores SciDev’s efforts to maintain active engagement with the market as it advances its portfolio of water treatment technologies across resource and infrastructure industries. Stakeholders will be looking to the presentation for insights into trading performance, project momentum and how its solutions are being adopted to address water reuse, efficiency and environmental challenges in key industrial sectors.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.35 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev switches auditors to BDO for 2026 oversight
Feb 4, 2026

SciDev named BDO Audit as its new external auditor after a competitive tender and ASIC-approved resignation of Ernst & Young, noting no disagreements with the outgoing firm. The board expects BDO to serve through the 2026 AGM, reinforcing governance stability and signaling continuity in financial oversight ahead of the next reappointment vote.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.39 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev Ltd Director Acquires Additional Shares
Dec 16, 2025

SciDev Ltd has announced a change in the director’s interest, with Johannes Risseeuw acquiring 70,000 fully paid ordinary shares through an on-market purchase at an average price of $0.43 per share. This acquisition reflects a strategic move by the director, potentially indicating confidence in the company’s future performance and stability, which may influence stakeholder perceptions and market positioning.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev Ltd Director Increases Shareholding with Significant Acquisition
Dec 8, 2025

SciDev Ltd has announced a change in the director’s interest, with Director Mike Utsler acquiring 55,000 fully paid ordinary shares through an on-market purchase at an average price of $0.44 per share. This acquisition increases his total shareholding to 117,111 shares, reflecting a significant personal investment in the company, which could indicate confidence in SciDev’s future performance and strategic direction.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 28, 2026